{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:51:06Z","timestamp":1767912666490,"version":"3.49.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s13760-018-0976-y","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T13:29:26Z","timestamp":1531488566000},"page":"361-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Infectious agents and different course of multiple sclerosis: a systematic review"],"prefix":"10.1007","volume":"118","author":[{"given":"Alia","family":"Saberi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"976_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ana.410310317","volume":"31","author":"DW Anderson","year":"1992","unstructured":"Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH (1992) Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neural 31:333\u2013336","journal-title":"Ann Neural"},{"key":"976_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0165-5728(98)00031-9","volume":"86","author":"H Lassmann","year":"1998","unstructured":"Lassmann H, Raine CS, Antel J, Prineas JW (1998) Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86:213\u2013217","journal-title":"J Neuroimmunol"},{"key":"976_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/135245859600200403","volume":"2","author":"DH Gilden","year":"1996","unstructured":"Gilden DH, Devlin ME, Burgoon MP, Owens GP (1996) The search for virus in multiple sclerosis brain. Mult Scler 2:179\u2013183","journal-title":"Mult Scler"},{"issue":"4","key":"976_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18869\/acadpub.cjns.2.4.9","volume":"2","author":"R Farid","year":"2016","unstructured":"Farid R, Norasteh A, Hatamian H (2016) The effect of core stability exercise program on the balance of patients with multiple sclerosis. Caspian J Neurol Sci 2(4):9\u201317","journal-title":"Caspian J Neurol Sci"},{"issue":"6","key":"976_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18869\/acadpub.cjns.2.6.1","volume":"2","author":"M Semnani","year":"2016","unstructured":"Semnani M, Mashayekhi F, Azarnia M, Salehi Z (2016) Effects of green tea epigallocatechin-3-gallate (EGCG) on proteolipid protein (PLP) and oligodendrocyte transcription factor 1 (Olig1) expression in the cerebral cortex of cuprizone induced multiple sclerosis mice; a western blot study. Caspian J Neurol Sci 2(6):1\u20139","journal-title":"Caspian J Neurol"},{"issue":"7","key":"976_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.18869\/acadpub.cjns.2.7.41","volume":"2","author":"M Saeidi","year":"2016","unstructured":"Saeidi M, Raftari S, Roudbary S, Rezaeitalab F, Hatamian H (2016) Peripheral neuro electrodiagnostic abnormalities in patients with multiple sclerosis: a cross sectional study. Caspian J Neurol Sci 2(7):41\u201348","journal-title":"Caspian J Neurol Sci"},{"issue":"10","key":"976_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.18869\/acadpub.cjns.3.10.151","volume":"3","author":"K Janalipour","year":"2017","unstructured":"Janalipour K, Kafi M, Hatamian H, Rezapour P (2017) The effectiveness of yoga therapy in reducing anxiety, stress and depression in women with multiple sclerosis. Caspian J Neurol Sci 3(10):151\u2013158","journal-title":"Caspian J Neurol Sci"},{"issue":"11","key":"976_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.29252\/nirp.cjns.3.11.175","volume":"3","author":"F Amir","year":"2017","unstructured":"Amir F, Ahadi H, Nikkhah K, Seirafi M (2017) The effectiveness of acceptance and commitment group therapy and group logotherapy in reducing perceived stress among MS patients. Caspian J Neurol Sci 3(11):175\u2013184","journal-title":"Caspian J Neurol Sci"},{"issue":"10","key":"976_CR9","first-page":"679","volume":"50","author":"A Saberi","year":"2012","unstructured":"Saberi A, Hatamian HR, Nemati SH, Banan R (2012) Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions. Acta Med Iran 50(10):679\u2013683","journal-title":"Acta Med Iran"},{"key":"976_CR10","first-page":"1","volume":"39","author":"A Saberi","year":"2012","unstructured":"Saberi A, Roudbary SA, Hatamian HR, Akbari MS, Sedigh-Rahim-Abadi MR (2012) The type of multiple sclerosis when accompanied with seizure: can seizure predict the progression of MS? Akt Neurol 39:1\u20135. (text in German)","journal-title":"Akt Neurol"},{"key":"976_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938\u2013952","journal-title":"N Engl J Med"},{"key":"976_CR12","first-page":"90711","volume":"46","author":"DF Lublin","year":"1996","unstructured":"Lublin DF, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907\u201311","journal-title":"Neurology"},{"issue":"8","key":"976_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18869\/acadpub.cjns.3.8.1","volume":"3","author":"M Etemadifar","year":"2017","unstructured":"Etemadifar M, Moeini P, Nabavi S (2017) Fingolimod versus high dose interferon beta-1a in multiple sclerosis: a randomized clinical trial. Caspian J Neurol Sci 3(8):1\u20138","journal-title":"Caspian J Neurol Sci"},{"issue":"10","key":"976_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.18869\/acadpub.cjns.3.10.128","volume":"3","author":"S Roudbary","year":"2017","unstructured":"Roudbary S, Yousefzadeh-Chabok S, Behzadnia H, Bakhshayesh-Eghbali B, Emamhadi M, Ghayeghran A et al (2017) Non-adherence to disease-modifying treatments in patients with multiple sclerosis. Caspian J Neurol Sci 3(10):128\u2013134","journal-title":"Caspian J Neurol Sci"},{"key":"976_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/ni1507","volume":"8","author":"HF McFarland","year":"2007","unstructured":"McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8:913\u2013919","journal-title":"Nat Immunol"},{"issue":"11","key":"976_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.29252\/nirp.cjns.3.11.214","volume":"3","author":"M Etemadifar","year":"2017","unstructured":"Etemadifar M, Ghadimi M, Ghadimi K, Alsahebfosoul F (2017) The serum amyloid \u03b2 level in multiple sclerosis: a case\u2013control study. Caspian J Neurol Sci 3(11):214\u2013221","journal-title":"Caspian J Neurol Sci"},{"key":"976_CR17","doi-asserted-by":"publisher","first-page":"39430","DOI":"10.1038\/srep39430","volume":"6","author":"MTC Walvoort","year":"2016","unstructured":"Walvoort MTC, Testa C, Eilam R et al (2016) Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of nontypeable Haemophilus influenzae. Sci Rep 6:39430. https:\/\/doi.org\/10.1038\/srep39430","journal-title":"Sci Rep"},{"issue":"4","key":"976_CR18","first-page":"165","volume":"12","author":"F Ashtari","year":"2007","unstructured":"Ashtari F, Saberi A, Shayegannejad V, Khosravi AR, Sherkat R, Khosravi E (2007) Association between Chlamydia pneumoniae infection and carotid atherosclerotic plaques. JRMS 12(4):165\u2013171","journal-title":"JRMS"},{"issue":"83","key":"976_CR19","first-page":"8","volume":"24","author":"F Ashtari","year":"2007","unstructured":"Ashtari F, Shayghannejad V, Saberi A, Karkheyran F, Khosravi E (2007) Chlamydia pneumonia infection and thrombotic ischemic stroke. J Isfahan Med School 24(83):8\u201314 [Text in Persian].","journal-title":"J Isfahan Med School"},{"issue":"3","key":"976_CR20","first-page":"130","volume":"2","author":"F Ashtari","year":"2006","unstructured":"Ashtari F, Shayegannejad V, Khosravi AR, Alia Saberi A, Niknazar MA (2006) The influence of Chlamydia pneumoniae infection on Intima-Media-thickness (IMT) in common carotid artery. ARYA Atheroscler 2(3):130\u2013133","journal-title":"ARYA Atheroscler"},{"issue":"14","key":"976_CR21","first-page":"8","volume":"5","author":"F Ashtari","year":"2006","unstructured":"Ashtari F, Shayghannejad V, Saberi A, Rabiei E (2006) Association between Helicobacter pylori infection and carotid atherosclerotic plaque. Iran J Neurol 5(14):8\u201314","journal-title":"Iran J Neurol"},{"issue":"4","key":"976_CR22","first-page":"303","volume":"46","author":"F Ashtari","year":"2008","unstructured":"Ashtari F, Shayegannejad V, Saberi A, Rabiei E (2008) Relationship between Helicobacter pylori immunoglobulin g antibody and thrombotic ischemic stroke. Acta Medica Iranica 46(4):303\u2013306","journal-title":"Acta Medica Iranica"},{"key":"976_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ana.21141","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Part II: noninfectious factors. Ann Neurol;61:288\u2013299. Ann Neurol 61:504\u2013513","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"976_CR24","first-page":"160","volume":"60","author":"A Szczucinski","year":"2006","unstructured":"Szczucinski A, Losy J (2006) Infectious agents in the pathogenesis of multiple sclerosis. Przegl Epidemiol 60(Suppl 1):160\u2013165","journal-title":"Przegl Epidemiol"},{"key":"976_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0167-5699(99)01509-1","volume":"20","author":"G Dighiero","year":"1999","unstructured":"Dighiero G, Rose NR (1999) Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. Immunol Today 20:423\u2013428","journal-title":"Immunol Today"},{"key":"976_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/clinids\/14.4.933","volume":"14","author":"T Banks","year":"1992","unstructured":"Banks T, Rouse B (1992) Herpesviruses\u2014immune escape artists? Clin Inf Dis 14:933\u2013941","journal-title":"Clin Inf Dis"},{"issue":"4","key":"976_CR27","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/jcp.26000","volume":"233","author":"A Pormohammad","year":"2018","unstructured":"Pormohammad A, Azimi T, Falah F, Faghihloo E (2018) Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta-analysis. J Cell Physiol 233(4):2850\u20132862","journal-title":"J Cell Physiol"},{"issue":"1\u20132","key":"976_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(02)00465-4","volume":"136","author":"RH Swanborg","year":"2003","unstructured":"Swanborg RH, Whittum-Hudson JA, Hudson AP (2003) Infectious agents and multiple sclerosis \u2013are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 136(1\u20132):1\u20138","journal-title":"J Neuroimmunol"},{"key":"976_CR29","first-page":"4","volume":"12","author":"J Fotheringham","year":"2005","unstructured":"Fotheringham J, Jacobson S (2005) Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease. Herpes 12;4\u20139","journal-title":"Herpes"},{"issue":"11","key":"976_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tim.2006.09.002","volume":"14","author":"CW Stratton","year":"2006","unstructured":"Stratton CW, Wheldon DB (2006) Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumonia. Trends Microbiol 14(11):474\u2013479","journal-title":"Trends Microbiol"},{"key":"976_CR31","first-page":"115","volume":"1","author":"SD Cook","year":"2004","unstructured":"Cook SD (2004) Does Epstein\u2013Barr virus cause multiple sclerosis? Rev Neurol Dis 1:115\u2013123","journal-title":"Rev Neurol Dis"},{"key":"976_CR32","first-page":"52","volume":"13","author":"T Christensen","year":"2006","unstructured":"Christensen T (2006) The role of EBV in MS pathogenesis. Int MS J 13:52\u201357","journal-title":"Int MS J"},{"key":"976_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archneur.61.4.529","volume":"61","author":"G Ordo\u02dcnez","year":"2004","unstructured":"Ordo\u02dcnez G, Pineda B, Garcia-Navarrete R, Sotelo J (2004) Brief presence of varicellazoster viral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol 61:529\u2013532","journal-title":"Arch Neurol"},{"key":"976_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1034\/j.1600-0404.2002.1o077.x","volume":"105","author":"R Tarrats","year":"2002","unstructured":"Tarrats R, Ordo\u02dcnez G, Rios C, Sotelo J (2002) Varicella, ephemeral breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans. Acta Neurol Scand 105:88\u201394","journal-title":"Acta Neurol Scand"},{"key":"976_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2334-6-23","volume":"6","author":"F Cirino","year":"2006","unstructured":"Cirino F, Webley WC, West C, Croteau NL, Andrzejewski C Jr, Stuart ES (2006) Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy, and flow cytometry techniques. BMC Infect Dis 6:23","journal-title":"BMC Infect Dis"},{"key":"976_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.msard.2016.03.013","volume":"7","author":"V Jaruvongvanich","year":"2016","unstructured":"Jaruvongvanich V, Sanguankeo A, Jaruvongvanich S, Upala S (2016) Association between Helicobacter pylori infection and multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 7:92\u201397","journal-title":"Mult Scler Relat Disord"},{"key":"976_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-3083.1993.tb02566.x","volume":"37","author":"ZY Wang","year":"1993","unstructured":"Wang ZY, Hansen K, Sid\u00e9n A, Cruz M (1993) Intrathecal synthesis of anti-Borrelia burgdorferi antibodies in neuroborreliosis: a study with special emphasis on oligoclonal IgM antibody bands. Scand J Immunol 37:369\u2013376","journal-title":"Scand J Immunol"},{"key":"976_CR38","first-page":"6","volume":"2","author":"G Sherbet","year":"2009","unstructured":"Sherbet G (2009) Bacterial infections and the pathogenesis of autoimmune conditions. Br J Med Pract 2:6\u201313","journal-title":"Br J Med Pract"},{"key":"976_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","volume":"155","author":"AM Ercolini","year":"2009","unstructured":"Ercolini AM, Miller SD (2009) The role of infections in autoimmune disease. Clin Exp Immunol 155:1\u201315","journal-title":"Clin Exp Immunol"},{"key":"976_CR40","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/ene.12759","volume":"22","author":"T Berger","year":"2015","unstructured":"Berger T, Reind M (2015) Antibody biomarkers in CNS demyelinating diseases\u2014a long and winding road. Eur J Neurol 22:1162\u20131168","journal-title":"Eur J Neurol"},{"key":"976_CR41","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000148","author":"MC Levin","year":"2013","unstructured":"Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Cooper Ch (2013) Autoantibodies to non-myelin antigens as contributors to the pathogenesis of multiple sclerosis. J Clin Cell Immunol. https:\/\/doi.org\/10.4172\/2155-9899.1000148","journal-title":"J Clin Cell Immunol"},{"key":"976_CR42","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.autrev.2014.07.002","volume":"13","author":"J Fraussen","year":"2014","unstructured":"Fraussen J, Claes N, de Bock L, Somers V (2014) Targets of the humoral autoimmune response in multiple sclerosis. Autoimmun Rev 13:1126\u20131137","journal-title":"Autoimmun Rev"},{"issue":"11","key":"976_CR43","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA et al (2016) STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaborate. BMJ Open 6(11): e012799","journal-title":"BMJ Open"},{"issue":"6","key":"976_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"52","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52(6):377\u2013384","journal-title":"J Epidemiol Community Health"},{"key":"976_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227\u2013231","journal-title":"Ann Neurol"},{"issue":"8","key":"976_CR46","doi-asserted-by":"publisher","first-page":"e105434","DOI":"10.1371\/journal.pone.0105434","volume":"9","author":"SC Wuest","year":"2014","unstructured":"Wuest SC, Mexhitaj I, Chai NR, Romm E, Scheffel J et al (2014) A complex role of herpes viruses in the disease process of multiple sclerosis. PLoS One 9(8):e105434","journal-title":"PLoS One"},{"key":"976_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/817238","author":"KA McKay","year":"2015","unstructured":"McKay KA, Kwan V, Duggan T, Tremlett H (2015) Risk factors associated with the onset of relapsing\u2013remitting and primary progressive multiple sclerosis: a systematic review. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/817238","journal-title":"Biomed Res Int"},{"issue":"2","key":"976_CR48","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/WNL.55.2.178","volume":"55","author":"K Wandinger","year":"2000","unstructured":"Wandinger K, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner H et al (2000) Association between clinical disease activity and Epstein\u2013Barr virus reactivation in MS. Neurology 55(2):178\u2013184","journal-title":"Neurology"},{"key":"976_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/08828240050144590","volume":"13","author":"C Cermelli","year":"2000","unstructured":"Cermelli C, Jacobson S (2000) Viruses and multiple sclerosis. Viral Immunol 13:255\u2013267","journal-title":"Viral Immunol"},{"key":"976_CR50","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1212\/01.WNL.0000069461.53733.F7","volume":"60","author":"P Villoslada","year":"2003","unstructured":"Villoslada P, Juste C, Tintore M, Lloren\u00e7 V, Codina G, Pozo-Rosich P et al (2003) The immune response against herpesvirus is more prominent in the early stages of MS. Neurology 60:1944\u20138","journal-title":"Neurology"},{"issue":"6","key":"976_CR51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/1352458511428081","volume":"18","author":"S Simpson Jr","year":"2012","unstructured":"Simpson S Jr, Taylor B, Dwyer DE, Taylor J, Blizzard L, Ponsonby AL et al (2012) Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Mult Scler 18(6):799\u2013806","journal-title":"Mult Scler"},{"issue":"8","key":"976_CR52","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1468-1331.2011.03410.x","volume":"18","author":"M Garcia-Montojo","year":"2011","unstructured":"Garcia-Montojo M, De Las Heras V, Dominguez-Mozo M, Bartolome M, Garcia-Martinez MA, Arroyo R et al (2011) Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients. Eur J Neurol 18(8):1027\u20131035","journal-title":"Eur J Neurol"},{"issue":"4","key":"976_CR53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmii.2010.08.002","volume":"44","author":"A Behzad-Behbahani","year":"2011","unstructured":"Behzad-Behbahani A, Mikaeili MH, Entezam M, Mojiri A, Pour GY, Arasteh MM et al (2011) Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J Microbiol Immunol Infect 44(4):247\u2013251","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"976_CR54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1600-0404.2009.01187.x","volume":"120","author":"M Ahram","year":"2009","unstructured":"Ahram M, El-Omar A, Baho Y, Lubad MA (2009) Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol Scand 120(6):430\u2013435","journal-title":"Acta Neurol Scand"},{"key":"976_CR55","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00001432-200106000-00016","volume":"14","author":"WC Koch","year":"2001","unstructured":"Koch WC (2001) Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 14:343\u2013356","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"976_CR56","first-page":"527","volume":"47","author":"Z Nora-Krukle","year":"2011","unstructured":"Nora-Krukle Z, Chapenko S, Logina I, Millers A, Platkajis A, Murovska M (2011) Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas) 47(10):527\u2013531","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"976_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clineuro.2008.07.007","volume":"111","author":"M Rodr\u00edguez-Violante","year":"2009","unstructured":"Rodr\u00edguez-Violante M, Ordo\u00f1ez G, Bermudez JR, Sotelo J, Corona T (2009) Association of a history of varicella virus infection with multiple sclerosis. Clin Neurol Neurosurg 111(1):54\u201356","journal-title":"Clin Neurol Neurosurg"},{"key":"976_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clineuro.2013.12.020","volume":"119","author":"J Sotelo","year":"2014","unstructured":"Sotelo J, Ordo\u00f1ez G, Pineda B, Flores J (2014) The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg 119:44\u201348","journal-title":"Clin Neurol Neurosurg"},{"key":"976_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","volume":"5","author":"A Ascherio","year":"2010","unstructured":"Ascherio A, Munger KL (2010) Epstein\u2013Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 5:271\u2013277","journal-title":"J Neuroimmune Pharmacol"},{"issue":"8258","key":"976_CR60","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0140-6736(81)91527-0","volume":"2","author":"HB Warner","year":"1981","unstructured":"Warner HB, Carp RI (1981) Multiple sclerosis and Epstein\u2013Barr virus. Lancet 2(8258):1290","journal-title":"Lancet"},{"key":"976_CR61","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor GS, Sauce D, Rickinson AB (2007) Cellular responses to viral infection in humans: lessons from Epstein\u2013Barr virus. Annu Rev Immunol 25:587\u2013617","journal-title":"Annu Rev Immunol"},{"key":"976_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/NEN.0b013e31827bfc62","volume":"72","author":"R Magliozzi","year":"2013","unstructured":"Magliozzi R, Serafini B, Rosicarelli B, Chiappetta G, Veroni C, Reynolds R et al (2013) B-cell enrichment and Epstein\u2013Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. J Neuropathol Exp Neurol 72:29\u201341","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"976_CR63","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP (2017) Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 140(3):527\u2013546","journal-title":"Brain"},{"issue":"Pt 7","key":"976_CR64","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/brain\/awn108","volume":"131","author":"S Jilek","year":"2008","unstructured":"Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A et al (2008) Strong EBV-specific CD8 + T-cell response in patients with early multiple sclerosis. Brain 131(Pt 7):1712\u20131721","journal-title":"Brain"},{"issue":"10","key":"976_CR65","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","volume":"78","author":"D Hochberg","year":"2004","unstructured":"Hochberg D, Souza T, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA (2004) Acute infection with Epstein\u2013Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 78(10):5194\u20135204","journal-title":"J Virol"},{"key":"976_CR66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","volume":"162","author":"AC van Sechel","year":"1999","unstructured":"van Sechel AC, Bajramovic JJ, van Stipdonk MJ, Persoon-Deen C, Geutskens SB, van Noort JM (1999) EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 162:129\u2013135","journal-title":"J Immunol"},{"issue":"1","key":"976_CR67","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.410370115","volume":"37","author":"P Rieckmann","year":"1995","unstructured":"Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A et al (1995) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing\u2013remitting multiple sclerosis is associated with disease activity. Ann Neurol 37(1):82\u201388","journal-title":"Ann Neurol"},{"issue":"Pt 1","key":"976_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/brain\/120.1.1","volume":"120","author":"G Giovannoni","year":"1997","unstructured":"Giovannoni G, Lai M, Kidd D, Thorpe JW, Miller DH, Thompson AJ et al (1997) Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. Brain 120(Pt 1):1\u201313","journal-title":"Brain"},{"issue":"3","key":"976_CR69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1399-0039.1998.tb03106.x","volume":"51","author":"M Ott","year":"1998","unstructured":"Ott M, Seidl C, Westhoff U, Stecker K, Seifried E, Fischer PA et al (1998) Soluble HLA class I and class II antigens in patients with multiple sclerosis. Tissue Antigens 51(3):301\u2013304","journal-title":"Tissue Antigens"},{"key":"976_CR70","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.2414848","volume":"230","author":"RS Fujinami","year":"1985","unstructured":"Fujinami RS, Oldstone MB (1985) Amino acid homology between the encephalolitogenic site of myelin basic protein and virus: mechanisms for autoimmunity. Science 230:1043\u20131045","journal-title":"Science"},{"key":"976_CR71","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","volume":"80","author":"KW Wucherpfennig","year":"1995","unstructured":"Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695\u2013705","journal-title":"Cell"},{"key":"976_CR72","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1084\/jem.185.9.1651","volume":"185","author":"B Hemmer","year":"1997","unstructured":"Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R et al (1997) Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 185:1651\u20131659","journal-title":"J Exp Med"},{"issue":"6","key":"976_CR73","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1084\/jem.182.6.1985","volume":"182","author":"A Windhagen","year":"1995","unstructured":"Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML et al (1995) Expression of costimulatory molecules B7\u20131 (CD80), B7\u20132 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 182(6):1985\u20131996","journal-title":"J Exp Med"},{"issue":"2","key":"976_CR74","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/jvi.34.2.560-568.1980","volume":"34","author":"BM Colby","year":"1980","unstructured":"Colby BM, Shaw JE, Elion GB, Pagano JS (1980) Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein\u2013Barr virus DNA replication. J Virol 34(2):560\u2013568","journal-title":"J Virol"},{"key":"976_CR75","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21640","volume":"65","author":"HL Weiner","year":"2009","unstructured":"Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous. Disease? Ann Neurol 65:239\u2013248","journal-title":"Ann Neurol"},{"issue":"1","key":"976_CR76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","volume":"73","author":"RA Farrell","year":"2009","unstructured":"Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J et al (2009) Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 73(1):32\u201338","journal-title":"Neurology"},{"issue":"2","key":"976_CR77","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bjid.2012.09.008","volume":"17","author":"N Ramroodi","year":"2013","unstructured":"Ramroodi N, Niazi AA, Sanadgol N, Ganjali Z, Sarabandi V (2013) Evaluation of reactive Epstein\u2013Barr virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS). Braz J Infect Dis 17(2):156\u2013163","journal-title":"Braz J Infect Dis"},{"issue":"10","key":"976_CR78","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/1352458511408991","volume":"17","author":"KL Munger","year":"2011","unstructured":"Munger KL, Levin LI, O\u2019Reilly EJ, Falk KI, Ascherio A (2011) Anti-Epstein\u2013Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 17(10):1185\u20131193","journal-title":"Mult Scler"},{"issue":"16","key":"976_CR79","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1212\/WNL.0b013e3182a841e4","volume":"81","author":"C Yea","year":"2013","unstructured":"Yea C, Tellier R, Chong P, Westmacott G, Marrie RA, Bar-Or A et al (2013) Epstein\u2013barr virus in oral shedding of children with multiple sclerosis. Neurology 81(16):1392\u20131399","journal-title":"Neurology"},{"issue":"11","key":"976_CR80","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1468-1331.2010.03083.x","volume":"17","author":"G Ingram","year":"2010","unstructured":"Ingram G, Bugert JJ, Loveless S, Robertson NP (2010) Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity. Eur J Neurol 17(11):1386\u20131389","journal-title":"Eur J Neurol"},{"issue":"4","key":"976_CR81","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neurobiolaging.2006.02.014","volume":"28","author":"E Boelen","year":"2007","unstructured":"Boelen E, Steinbusch HW, van der Ven AJ, Grauls G, Bruggeman CA, Stassen FR (2007) Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol Aging 28(4):524\u2013532","journal-title":"Neurobiol Aging"},{"issue":"2","key":"976_CR82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0028-3843(14)60023-2","volume":"45","author":"M Aghaei","year":"2011","unstructured":"Aghaei M, Ashtari F, Bahar M, Falahian MR (2011) Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: a pilot study. Neurol Neurochir Pol 45(2):128\u2013131","journal-title":"Neurol Neurochir Pol"},{"issue":"5\u20136","key":"976_CR83","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/BF01878008","volume":"26","author":"E Rindfleisch","year":"1863","unstructured":"Rindfleisch E (1863) Histologisches detail zu der grauen degeneration von gehirn und ruckenmark. Arch Pathol Anat Physiol 26(5\u20136):474\u2013483","journal-title":"Arch Pathol Anat Physiol"},{"key":"976_CR84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.arr.2003.08.005","volume":"3","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 3:105\u2013120","journal-title":"Ageing Res Rev"},{"issue":"4","key":"976_CR85","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1191\/1352458504ms1049oa","volume":"10","author":"C Contini","year":"2004","unstructured":"Contini C, Cultrera R, Seraceni S, Castellazzi M, Granieri E, Fainardi E (2004) Cerebrospinal fluid molecular demonstration of Chlamydia pneumonia DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing\/remitting multiple sclerosis. Mult Scler 10(4):360\u2013369","journal-title":"Mult Scler"},{"issue":"2","key":"976_CR86","first-page":"141","volume":"14","author":"KL Munger","year":"2003","unstructured":"Munger KL, Peeling RW, Hern\u00e1n MA, Chasan-Taber L, Olek MJ, Hankinson SE et al (2003) Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology 14(2):141\u20137","journal-title":"Epidemiology"},{"issue":"10","key":"976_CR87","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1212\/01.WNL.0000125193.58601.2C","volume":"62","author":"KL Munger","year":"2004","unstructured":"Munger KL, DeLorenze GN, Levin LI, Rubertone MV, Vogelman JH, Peck CA et al (2004) A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology 62(10):1799\u20131803","journal-title":"Neurology"},{"issue":"1","key":"976_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/135245850100700103","volume":"7","author":"D Krametter","year":"2001","unstructured":"Krametter D, Niederwieser G, Berghold A, Birnbaum G, Strasser-Fuchs S, Hartung HP et al (2001) Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 7(1):13\u201318","journal-title":"Mult Scler"},{"issue":"2","key":"976_CR89","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jns.2003.09.012","volume":"217","author":"E Fainardi","year":"2004","unstructured":"Fainardi E, Castellazzi M, Casetta I, Cultrera R, Vaghi L, Granieri E et al (2004) Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated with a subset of multiple sclerosis patients with progressive forms. J Neurol Sci 217(2):181\u2013188","journal-title":"J Neurol Sci"},{"issue":"2","key":"976_CR90","first-page":"101","volume":"6","author":"HT Agostini","year":"2000","unstructured":"Agostini HT, Ryschkewitsch CF, Baumhefner RW, Tourtellotte WW, Singer EJ, Komoly S et al (2000) Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy. J Neurovirol 6(2):101\u2013108","journal-title":"J Neurovirol"},{"issue":"3\u20134","key":"976_CR91","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1155\/2000\/590914","volume":"16","author":"HB Rasmussena","year":"2000","unstructured":"Rasmussena HB, Kellyb MA, Francisc DA, Clausena J (2000) Association between the endogenous retrovirus HRES-1 and multiple sclerosis in the United Kingdom\u2014evidence of genetically different disease subsets? Dis Markers 16(3\u20134):101\u2013104","journal-title":"Dis Markers"},{"issue":"9","key":"976_CR92","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1086\/319983","volume":"32","author":"PK Chan","year":"2001","unstructured":"Chan PK, Tam WH, Yeo W, Cheung JL, Zhong S, Cheng AF (2001) High carriage rate of TT virus in the cervices of pregnant women. Clin Infect Dis 32(9):1376\u20131377","journal-title":"Clin Infect Dis"},{"issue":"2","key":"976_CR93","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.virol.2009.08.036","volume":"394","author":"J Rocchi","year":"2009","unstructured":"Rocchi J, Ricci V, Albani M, Lanini L, Andreoli E, Macera L et al (2009) Torque teno virus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9. Virology 394(2):235\u201342","journal-title":"Virology"},{"issue":"12","key":"976_CR94","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/jmv.23707","volume":"85","author":"R Mancuso","year":"2013","unstructured":"Mancuso R, Saresella M, Hernis A, Agostini S, Piancone F, Caputo D et al (2013) Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease. J Med Virol 85(12):2176\u20132183","journal-title":"J Med Virol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-018-0976-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-0976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-0976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:18:35Z","timestamp":1744175915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-018-0976-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s13760-018-0976-y","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors confirm independence from the sponsors; the content of the article has not been influenced by the sponsors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}